一种利用临床常规数据确定活动式经皮骨导植入装置患者个体最大输出的新方法
研究纳入2011至2020年植入Bonebridge的71例患者(平均年龄45±19岁,范围5至84岁),利用患者听力计骨导阈值、直接骨导阈值及装置最大力输出计算最大输出听力级(MOHL)。同侧听力计骨导阈值较好组平均同侧MOHL在0.5至6 kHz为51至73 dB HL,对侧较好组平均对侧MOHL为43至67 dB HL,同侧较好组各频率平均MOHL比对侧较好组高4至8 dB。
要点
- 利用临床常规听力计和直接骨导阈值数据可确定经皮骨导装置个体频率特异性MOHL。
- 同侧(植入侧)平均MOHL比对侧高4至8 dB。
- 数据变异度约为6至11 dB(标准差),各测量频率组间差异显著(t检验;p < 0.05)。
核心结论
- 所提出的方法表明,主要利用患者临床常规的直接和听力计骨导阈值数据,可确定经皮骨导装置个体患者同侧和对侧的频率特异性MOHL;植入物平均MOHL在同侧(植入侧)比对侧高4至8 dB。
研究设计与样本
- 研究纳入2011至2020年间植入Bonebridge的71例患者,平均年龄45±19岁,范围5至84岁。
- 利用患者听力计和直接骨导阈值及听力阈值对应力级和装置最大力输出计算MOHL(dB HL)。
- 分析按同侧平均听力计骨导阈值(0.5、1、2、4 kHz)较好或较差分组,或按同侧(植入侧)逐频率听力计骨导阈值较好或较差分离MOHL。
主要发现
- 同侧耳听力计骨导阈值较好组,0.5至6 kHz频率的平均同侧MOHL范围为51至73 dB HL。
- 对侧听力较好组平均对侧MOHL范围为43至67 dB HL。
- 各测量频率(0.5至6 kHz)数据变异度约为6至11 dB(标准差)。
- 同侧耳听力计骨导阈值较好组各频率平均MOHL比对侧耳听力计骨导阈值较好组高4至8 dB。
- 组间差异在各测量频率均显著(t检验;p < 0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The maximum output provided by a bone conduction (BC) device is one of the main factors that determines the success when treating patients with conductive or mixed hearing loss. Different approaches such as sound pressure measurements using a probe microphone in the external auditory canal or a surface microphone on the forehead have been previously introduced to determine the maximum output of active transcutaneous BC devices that are not directly accessible after implantation. Here, we introduce a method to determine the maximum output hearing level (MOHL) of a transcutaneous active BC device using patients' audiometric data. DESIGN: We determined the maximum output in terms of hearing level MOHL (dB HL) of the Bonebridge using the audiometric and direct BC threshold of the patient together with corresponding force levels at hearing threshold and the maximum force output of the device. Seventy-one patients implanted with the Bonebridge between 2011 and 2020 (average age 45 ± 19 years ranging from 5 to 84 years) were included in this study. The analyses of MOHLs were performed by (1) dividing patients into two groups with better or worse average audiometric BC threshold (0.5, 1, 2, 4 kHz), on the ipsilateral side or (2) by separating the MOHLs based on better or worse frequency-by-frequency specific audiometric BC thresholds on the ipsilateral (implanted) side. RESULTS: When using a frequency-by-frequency analysis obtained average ipsilateral MOHLs were in the range between 51 and 73 dB HL for frequencies from 0.5 to 6 kHz in the group with better audiometric BC threshold on the ipsilateral ears. The average contralateral MOHLs in the group with better contralateral hearing were in the range from 43 to 67 dB HL. The variability of the data was approximately 6 to 11 dB (SDs) across measured frequencies (0.5 to 6 kHz). The average MOHLs were 4 to 8 dB higher across frequencies in the group with better audiometric BC threshold on the ipsilateral ears than in the group with better audiometric BC threshold on the contralateral ears. The differences between groups were significant across measured frequencies ( t test; p < 0.05). CONCLUSIONS: Our proposed method demonstrates that the individual frequency-specific MOHL on the ipsilateral and contralateral side of individual patients with a transcutaneous BC device can be determined mainly using direct and audiometric BC threshold data of the patients from clinical routine. The average MOHL of the implant was found 4 to 8 dB higher on the ipsilateral (implanted) side than on the contralateral side.
引用
- Ghoncheh M, Busch S, Lenarz T, et al. A Novel Method to Determine the Maximum Output of Individual Patients for an Active Transcutaneous Bone Conduction Implant Using Clinical Routine Data. Ear Hear. 2023. PMID: 37580866. doi:10.1097/AUD.0000000000001415
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。